SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-04-001507
Filing Date
2004-05-13
Accepted
2004-05-13 16:12:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 d476954_13g-a.txt SC 13G/A 18885
  Complete submission text file 0000919574-04-001507.txt   20665
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47221 | Film No.: 04803159
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PORTER FELLMAN INC 100 PARK AVENUE SUITE 2120 NEW YORK NY 10017
Business Address C/O PORTER FELLMAN INC 100 PARK AVENUE SUITE 2120 NEW YORK NY 10017
PORTER A ALEX (Filed by) CIK: 0001120329 (see all company filings)